|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to Reuters Health News Archives
Reuters Health News: 10-18-2004
LONDON (Reuters) - Veterans of the Gulf War suffer more health problems than other members of the military but the causes of the mysterious array of symptoms may never be known, a leading British scientist said on Monday.
LOS ANGELES (Reuters) - Enbrel, the rheumatoid arthritis drug sold by Amgen Inc. and Wyeth, can stop joint damage when given to patients in combination with an older drug, researchers said on Monday.
NEW YORK (Reuters) - Pfizer Inc. said on Monday it plans to sponsor a major clinical study to further assess the cardiovascular safety of its arthritis drug Celebrex following the withdrawal of Merck & Co.'s Vioxx, a drug in the same class.
NEW YORK (Reuters Health) - Women who are thinking about becoming pregnant are usually advised to stay away from alcoholic beverages. Now, new research suggests that their partners should do the same.
LONDON (Reuters) - A leading anti-smoking group accused the British government Monday of sitting on a confidential report which confirms the health dangers of passive smoking.
NEW YORK (Reuters) - Eli Lilly and Co.'s new antidepressant Cymbalta was shown in a small clinical trial to be effective in reducing pain in women suffering from fibromyalgia, a chronic disorder that causes widespread pain in the muscles and soft tissues, researchers said.
NEW YORK (Reuters) - Bristol-Myers Squibb Co. said on Sunday its experimental drug for rheumatoid arthritis showed highly promising results in two late-stage clinical trials.
SINGAPORE (Reuters) - A rare outbreak of cholera in Singapore has killed an 89-year-old man, among nine people infected, and authorities are trying to trace the source of the disease, the government said Monday.
HONG KONG (Reuters) - To prevent a winter return of the deadly SARS virus, a senior Chinese health official will visit southern Guangdong province this month to map out measures such as banning civet cat from menus, a newspaper said on Monday.
WASHINGTON (Reuters) - None of Chiron Corp.'s CHIR.O flu vaccine made at a British plant is safe, which means the U.S. flu vaccine supply will be half of what was expected, U.S. health officials said on Friday.
|
|
